|
a |
|
b/man/data-lpdAll.Rd |
|
|
1 |
\name{lpdAll} |
|
|
2 |
\alias{lpdAll} |
|
|
3 |
\docType{data} |
|
|
4 |
\title{ |
|
|
5 |
An assembly of drug viability data, methylation clusters, important mutations and copy number variants |
|
|
6 |
} |
|
|
7 |
\description{ |
|
|
8 |
Columns indicate patients and rows different omics features. |
|
|
9 |
|
|
|
10 |
\code{pData()} contains some basic patient characteristics. |
|
|
11 |
|
|
|
12 |
\code{fData()$type} contains information to which omics data type each feature belongs to: |
|
|
13 |
|
|
|
14 |
|
|
|
15 |
1) viab (viability values for n=448 data points): 'D_001' stands for the drug as coded in the object \code{\link{drugs}} and '_01' indicates the concentration step. '_1:5' corresponds to the average across all five concentration steps and '_4:5' corresponds to all the concentration steps . |
|
|
16 |
2) gen (n=89): important gene mutations and copy number variants derived from WES, SNP arrays, FISH and targeted sequencing. |
|
|
17 |
3) Methylation_Cluster: The association of each CLL patient with one of the three Methylation Cluster was determined as described in the methods section. |
|
|
18 |
4) IGHV mutation status for CLL patients was determined as described in the methods section. |
|
|
19 |
|
|
|
20 |
} |
|
|
21 |
\author{Wolfgang Huber} |
|
|
22 |
\usage{ |
|
|
23 |
lpdAll |
|
|
24 |
} |
|
|
25 |
\format{ |
|
|
26 |
\code{"\linkS4class{ExpressionSet}"} with Features 539 and Samples 249. |
|
|
27 |
} |
|
|
28 |
\keyword{datasets} |